Comparison of Outcomes of Dexmedetomidine vs Midazolam for Sedation in Mechanically Ventilated Neurosurgical Patients
Sadaf Zehra, Samrah Shafqat, Shahneela Raza, Alina Siddiqui, Sobia Qamer, Shoaib Akhtar
Abstract
Open-access reader
Sadaf Zehra, Samrah Shafqat, Shahneela Raza, Alina Siddiqui, Sobia Qamer, Shoaib Akhtar
Abstract
Open-access reader
Aim: To compare the outcomes of dexmedetomidine versus midazolam for sedation in mechanically ventilated neurosurgical patients at Tertiary Care Hospital, Karachi. Study design: Randomized control trial. Place and duration of study: Department of Anesthesia, JPMC, Karachi from 20th November 2020 to 20th May 2021. Methodology: One hundred patients who met the diagnostic criteria were enrolled. Brief history was taken and demographic information was noted. Results: Mean ages and duration of mechanical ventilations in dexmedetomidine group was 49.78±10.54 years and 93.54±10.53 hours while in midazolam group was 50.41±12.39 years and 117.50±15.51 hours. Mean extubation time in the dexmedetomidine and midazolam group was 35.27±0.57 minutes and 48.84±0.53 minutes and statistically the difference was significant (P=0.01). Whereas, mean Ramsay sedation score in the dexmedetomidine and midazolam group was 3.03±0.04 and 3.92±0.06. P-value was 0.01. Conclusion: Dexemedetomidine prove to be drug of good choice for sedation during neurosurgical mechanism as compared to midazolam. It also showed good extubation time and hemodynamic stability. Keywords: Dexmedetomidine, Midazolam, Sedation, Mechanically ventilated, Hemodynamic changes, Neuro-protection
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Aim: To compare the outcomes of dexmedetomidine versus midazolam for sedation in mechanically ventilated neurosurgical patients at Tertiary Care Hospital, Karachi. Study design: Randomized control trial. Place and duration of study: Department of Anesthesia, JPMC, Karachi from 20th November 2020 to 20th May 2021. Methodology: One hundred patients who met the diagnostic criteria were enrolled. Brief history was taken and demographic information was noted. Results: Mean ages and duration of mechanical ventilations in dexmedetomidine group was 49.78±10.54 years and 93.54±10.53 hours while in midazolam group was 50.41±12.39 years and 117.50±15.51 hours. Mean extubation time in the dexmedetomidine and midazolam group was 35.27±0.57 minutes and 48.84±0.53 minutes and statistically the difference was significant (P=0.01). Whereas, mean Ramsay sedation score in the dexmedetomidine and midazolam group was 3.03±0.04 and 3.92±0.06. P-value was 0.01. Conclusion: Dexemedetomidine prove to be drug of good choice for sedation during neurosurgical mechanism as compared to midazolam. It also showed good extubation time and hemodynamic stability. Keywords: Dexmedetomidine, Midazolam, Sedation, Mechanically ventilated, Hemodynamic changes, Neuro-protection
Key concepts: Dexmedetomidine, Midazolam, Sedation, Medicine, Anesthesia, Hemodynamics